Table 3.
Comparison of patients with and without disease control.
| Parameters | Disease control, n (%) | P value | |
|---|---|---|---|
| No, n = 17 | Yes, n = 48 | ||
| Male sex | 15 (88.2) | 39 (81.3) | .713 |
| Age ≥ 65 years | 7 (41.2) | 24 (50) | .531 |
| Viral hepatitis | 7 (41.2) | 22 (45.8) | .740 |
| Cirrhosis | 6 (35.3) | 21 (43.8) | .543 |
| ECOG-PS ≥ 1 | 7 (41.2) | 20 (41.7) | .972 |
| AFP, median (range), ng/mL | 1000 (1.4–409220) | 40.8 (1.8–81658) | .047 |
| Child-Pugh class B | 3 (17.6) | 4 (8.3) | .366 |
| NLR, median (range) | 3.09 (0.65–9.12) | 3.01 (1.14–18.3) | .964 |
| Extrahepatic spread | 10 (58.8) | 26 (54.2) | .740 |
| Antibiotic use* | 4 (23.5) | 3 (6.3) | .048 |
Bold values indicate statistical significance.
AFP = alpha-fetoprotein, ECOG-PS = Eastern Cooperative Oncology Group-Performance Status, NLR = neutrophil-to-lymphocyte ratio.
*
Concurrent use of antibiotics with immunotherapy.